Anthony Quinn Insider Trading $AGLE Aeglea BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anthony Quinn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony Quinn. Anthony Quinn is EVP, CMO & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and EVP, CMO, & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and Interim CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and interim Chief Medical Officer in Aeglea BioTherapeutics, Inc. ($AGLE) and President & CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and Director in Generation Bio Co. ($GBIO) and Director in Kaleido Biosciences, Inc. ($KLDO).
Anthony Quinn in Aeglea BioTherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anthony Quinn: President & CEO, Interim CEO, interim Chief Medical Officer, Director
Holdings: 538,469 shares
Current Value: $2,256,185
Latest Transaction: Feb 19 2021
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Anthony Quinn in Aeglea BioTherapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGLE, GBIO, KLDO, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 7.35 | 330,000 | 2,425,500 | 330,000 | |
| May 04 2020 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 4.75 | 165,000 | 783,750 | 538,469 | 373.5 K to 538.5 K (+44.18 %) |
| Feb 19 2020 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 8.15 | 301,000 | 2,453,150 | 301,000 | |
| Oct 07 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 6.31 | 17,603 | 111,075 | 119,914 | |
| Oct 07 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 5.46 | 662 | 3,615 | 0 | |
| Oct 07 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 6.31 | 17,603 | 111,075 | 371,908 | 354.3 K to 371.9 K (+4.97 %) |
| Oct 07 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 5.46 | 662 | 3,615 | 354,305 | 353.6 K to 354.3 K (+0.19 %) |
| Jun 14 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.23 | 5,282 | 32,913 | 353,643 | 348.4 K to 353.6 K (+1.52 %) |
| Jun 14 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.17 | 14,406 | 88,836 | 348,361 | 334 K to 348.4 K (+4.31 %) |
| Jun 14 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.11 | 12,217 | 74,705 | 333,955 | 321.7 K to 334 K (+3.80 %) |
| May 22 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.86 | 3,809 | 26,128 | 321,738 | 317.9 K to 321.7 K (+1.20 %) |
| May 22 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.89 | 13,794 | 94,981 | 317,929 | 304.1 K to 317.9 K (+4.54 %) |
| May 22 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.56 | 8,989 | 58,923 | 304,135 | 295.1 K to 304.1 K (+3.05 %) |
| May 17 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.65 | 6,218 | 41,335 | 295,146 | 288.9 K to 295.1 K (+2.15 %) |
| May 17 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.83 | 5,520 | 37,691 | 288,928 | 283.4 K to 288.9 K (+1.95 %) |
| May 17 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.76 | 6,256 | 42,269 | 283,408 | 277.2 K to 283.4 K (+2.26 %) |
| May 17 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 7.10 | 719 | 5,103 | 277,152 | 276.4 K to 277.2 K (+0.26 %) |
| Feb 08 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 6.31 | 7,433 | 46,902 | 137,517 | |
| Feb 08 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 5.46 | 1,323 | 7,224 | 662 | |
| Feb 08 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 6.31 | 7,433 | 46,902 | 276,433 | 269 K to 276.4 K (+2.76 %) |
| Feb 08 2019 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 5.46 | 1,323 | 7,224 | 269,000 | 267.7 K to 269 K (+0.49 %) |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 6.31 | 18,584 | 117,265 | 144,950 | |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 5.46 | 3,306 | 18,051 | 1,985 | |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | M | 4.11 | 150,000 | 616,500 | 0 | |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 6.31 | 18,584 | 117,265 | 267,677 | 249.1 K to 267.7 K (+7.46 %) |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 5.46 | 3,306 | 18,051 | 249,093 | 245.8 K to 249.1 K (+1.35 %) |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | M | 4.11 | 150,000 | 616,500 | 245,787 | 95.8 K to 245.8 K (+156.60 %) |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 9.13 | 994 | 9,075 | 95,787 | 94.8 K to 95.8 K (+1.05 %) |
| Dec 10 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 6.02 | 2,000 | 12,040 | 94,793 | 92.8 K to 94.8 K (+2.16 %) |
| Jul 20 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 9.36 | 50,000 | 468,000 | 50,000 | |
| Jul 20 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 9.36 | 75,000 | 702,000 | 75,000 | |
| Jul 20 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 9.36 | 75,000 | 702,000 | 75,000 | |
| Jul 20 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 9.36 | 300,000 | 2,808,000 | 300,000 | |
| Jul 16 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Option Exercise | M | 6.31 | 14,866 | 93,804 | 163,534 | |
| Jul 16 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Option Exercise | M | 7.04 | 24,000 | 168,960 | 0 | |
| Jul 16 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | M | 6.31 | 14,866 | 93,804 | 92,793 | 77.9 K to 92.8 K (+19.08 %) |
| Jul 16 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | M | 7.04 | 24,000 | 168,960 | 77,927 | 53.9 K to 77.9 K (+44.50 %) |
| Jul 13 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Option Exercise | M | 5.46 | 3,307 | 18,056 | 5,291 | |
| Jul 13 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | M | 5.46 | 3,307 | 18,056 | 53,927 | 50.6 K to 53.9 K (+6.53 %) |
| Feb 22 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Option Exercise | A | 6.31 | 178,400 | 1,125,704 | 178,400 | |
| Feb 20 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Option Exercise | M | 5.46 | 15,211 | 83,052 | 8,598 | |
| Feb 20 2018 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | M | 5.46 | 15,211 | 83,052 | 50,620 | 35.4 K to 50.6 K (+42.96 %) |
| Dec 08 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | P | 5.07 | 600 | 3,039 | 35,409 | 34.8 K to 35.4 K (+1.72 %) |
| Dec 08 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | P | 4.99 | 2,800 | 13,967 | 34,809 | 32 K to 34.8 K (+8.75 %) |
| Dec 08 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | P | 4.92 | 4,888 | 24,072 | 32,009 | 27.1 K to 32 K (+18.02 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Director | Buy | P | 4.93 | 5,065 | 24,976 | 27,121 | 22.1 K to 27.1 K (+22.96 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Director | Buy | P | 4.98 | 7,956 | 39,624 | 22,056 | 14.1 K to 22.1 K (+56.43 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Director | Buy | P | 4.53 | 4,100 | 18,578 | 14,100 | 10 K to 14.1 K (+41.00 %) |
| Sep 01 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Option Exercise | A | 4.11 | 150,000 | 616,500 | 150,000 | |
| Apr 25 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony | interim Chief Medic ... | Option Exercise | A | 7.04 | 24,000 | 168,960 | 24,000 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony | Director | Buy | P | 10.00 | 10,000 | 100,000 | 10,000 | 0 to 10 K |
Page: 1